SlidesetHIVCanadian HIV Clinical Forum 2018Monitoring and avoiding integrase inhibitor toxicity- Gordon Arbess, MD, CCFPView Slideset
SlidesetHIVCanadian HIV Clinical Forum 2018State of the ART: What’s the same – what’s different – Is it clinicially relevant?- Eric Arts, PhDView Slideset
ATAlice TsengB.Sc.Phm., PharmD, FCSHP, AAHIVPSlidesetHIVCanadian HIV Clinical Forum 2018Managing drug-drug interactions in patients with multiple co-medications- Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVPView Slideset
CFCharles FlexnerMDSlidesetHIVCanadian HIV Clinical Forum 2018State of the ART: What’s the same – what’s different – is it clinicially relevant?- Charles Flexner, MDView Slideset
HZHongxin ZhaoMD, MPHSlidesetHIVChinese HIV Clinical Forum 2018Long-term HIV treatment: The Importance of Initial Antiretroviral Regimen Selection- Hongxin Zhao, MD, MPHView Slideset
CHChien-Ching HungMD, PhDSlidesetHIVChinese HIV Clinical Forum 2018Taiwan’s Experiences with Integrase Inhibitors- Chien-Ching Hung, MD, PhDView Slideset
SlidesetHIVChinese HIV Clinical Forum 2018Abstract-driven presentation: Efficacy and Safety of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide (E/C/F/TAF) in Virologically Suppressed Asian Adults with Renal Impairment: 144 Week- Ning LiView Slideset
SlidesetHIVChinese HIV Clinical Forum 2018Optimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhDView Slideset
KBKees BrinkmanMD, PhDSlidesetHIVChinese HIV Clinical Forum 2018Optimal use of integrase inhibitors in routine clinical practice- Kees Brinkman, MD, PhDView Slideset
SlidesetHIVChinese HIV Clinical Forum 2018Resistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhDView Slideset
SlidesetHIVChinese HIV Clinical Forum 2018Abstract-driven presentation: Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Treatment-Naïve Asian Adults: Week 144 results- Tina ZhengView Slideset
CBCharles BoucherMD, PhDSlidesetHIVChinese HIV Clinical Forum 2018Resistance Characteristics of different Integrase Inhibitors- Charles Boucher, MD, PhDView Slideset